Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study
High-flow nasal therapy (HFNT) provides several pathophysiological benefits in chronic respiratory disorders. We aimed to evaluate the effectiveness of long-term HFNT in patients with bronchiectasis (BE). Methods: This is a retrospective bicentric case-control study of outpatients with BE on optimiz...
Main Authors: | Claudia Crimi, Santi Nolasco, Raffaele Campisi, Mattia Nigro, Pietro Impellizzeri, Andrea Cortegiani, Alberto Noto, Andrea Gramegna, Carlo Vancheri, Francesco Blasi, Nunzio Crimi, Stefano Aliberti, Annalisa Carlucci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/24/7323 |
Similar Items
-
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report
by: Pietro Impellizzeri, et al.
Published: (2022-08-01) -
Asymmetrical high-flow nasal cannula performs similarly to standard interface in patients with acute hypoxemic post-extubation respiratory failure: a pilot study
by: Annalisa Boscolo, et al.
Published: (2024-01-01) -
The Danish respiratory society guideline for long-term high flow nasal cannula treatment, with or without supplementary oxygen
by: Ulla Møller Weinreich, et al.
Published: (2023-01-01) -
Should We Use High-Flow Nasal Cannula in Patients Receiving Gastrointestinal Endoscopies? Critical Appraisals through Updated Meta-Analyses with Multiple Methodologies and Depiction of Certainty of Evidence
by: Chi Chan Lee, et al.
Published: (2022-07-01) -
ROX index versus HACOR scale in predicting success and failure of high-flow nasal cannula in the emergency department for patients with acute hypoxemic respiratory failure: a prospective observational study
by: Nattakarn Praphruetkit, et al.
Published: (2023-01-01)